CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder

被引：0
|
作者：
Guoliang Yang
Lianhua Zhang
Mengyao Liu
Qiang liu
Xuehui Duan
Juanjie Bo
机构：
[1] Shanghai Jiao Tong University,Department of Urology, Ren Ji Hospital, School of Medicine
[2] Shanghai Jiao Tong University,Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine
[3] Shanghai Jiao Tong University,Department of Pathology, Ren Ji Hospital, School of Medicine
来源：
World Journal of Urology | 2019年 / 37卷
关键词：
Bladder cancer; T1 high grade; CD163+ macrophage; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2721 / 2726
页数：5
相关论文
共 50 条
  • [31] High-grade T1 bladder cancer at the ureterovesical junction: Commentary
    Soloway M.
    Bochner
    Dinney
    Current Urology Reports, 2007, 8 (2) : 104 - 107
  • [32] The best treatment for high-grade T1 bladder cancer is cystectomy
    Skinner, Eila C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (06) : 523 - 525
  • [33] HIGH-GRADE T1 BLADDER CANCER: IS A SECOND RESECTION IMPERATIVE?
    Branchereau, Julien
    Luyckx, Francois
    Karam, Georges
    Bouchot, Olivier
    Rigaud, Jerome
    JOURNAL OF UROLOGY, 2011, 185 (04): : E700 - E700
  • [34] Outcomes of patients with clinical T1 grade 3 bladder urothelial cell bladder carcinoma treated with radical cystectomy
    Gupta, Amit
    Shariat, Shahrokh F.
    Nielson, Matthew
    Bastian, Patrick J.
    Palapattu, Ganesh S.
    Rogers, Crag G.
    Vazina, Amnon
    Karakiewicz, Pierre I.
    Schoenberg, Mark P.
    Lerner, Seth P.
    Sagalowsky, Arthur I.
    Lotan, Yair
    JOURNAL OF UROLOGY, 2007, 177 (04): : 498 - 499
  • [35] Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
    Michaela Bowden
    Rosa Nadal
    Chensheng W. Zhou
    Lillian Werner
    Justine Barletta
    Nuria Juanpere
    Josep Lloreta
    Silvia Hernandez-Llodrà
    Juan Morote
    Ines de Torres
    Anna Orsola
    Paloma Cejas
    Henry Long
    Joaquim Bellmunt
    Scientific Reports, 10
  • [36] Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
    Bowden, Michaela
    Nadal, Rosa
    Zhou, Chensheng W.
    Werner, Lillian
    Barletta, Justine
    Juanpere, Nuria
    Lloreta, Josep
    Hernandez-Llodra, Silvia
    Morote, Juan
    de Torres, Ines
    Orsola, Anna
    Cejas, Paloma
    Long, Henry
    Bellmunt, Joaquim
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] CLINICAL OUTCOME IN PATIENTS WITH T1 MICROPAPILLARY UROTHELIAL CARCINOMA OF THE BLADDER
    Spaliviero, Massimiliano
    Dalbagni, Guido
    Bochner, Bernard H.
    Poon, Bing Ying
    Donahue, Timothy F.
    Al-Ahmadie, Hikmat A.
    Taylor, Jennifer M.
    Meeks, Joshua J.
    Huang, Hongying
    Sjoberg, Daniel D.
    Donat, S. Machele
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E727 - E728
  • [38] Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder
    Spaliviero, Massimiliano
    Dalbagni, Guido
    Bochner, Bernard H.
    Poon, Bing Ying
    Huang, Hongying
    Al-Ahmadie, Hikmat A.
    Donahue, Timothy F.
    Taylor, Jennifer M.
    Meeks, Joshua J.
    Sjoberg, Daniel D.
    Donat, S. Machele
    Reuter, Victor E.
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2014, 192 (03): : 702 - 707
  • [39] Recurrence and upstaging rates of T1 high-grade urothelial carcinoma of the bladder on repeat resection in a Canadian, resource-limited, healthcare system
    Kinnaird, Adam
    Dromparis, Peter
    Evans, Howard
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (08): : 267 - 269
  • [40] Difficult decisions in urologic oncology: Management of high-grade T1 transitional cell carcinoma of the bladder
    Soloway, Mark S.
    Lee, Cheryl T.
    Steinberg, Gary D.
    Ghandi, Abdullah Al
    Jewett, Michael A. S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (04) : 338 - 340
12345